Lack of neuropathy-related phenotypes in Hint1 knockout mice

Journal of Neuropathology and Experimental Neurology

Volumn 73, Issue 7, 2014, Pages 693-701

  Seburn, Kevin L ^a   Morelli, Kathryn H ^a,b   Jordanova, Albena ^c,d   Burgess, Robert W ^a,b  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Animal model; Axon degeneration; Charcot Marie Tooth disease; HINT1; Histidine triad nucleotide binding protein 1; Neuromyotonia

Indexed keywords

3,4 DIAMINOPYRIDINE; HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1; NUCLEOTIDE BINDING PROTEIN; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DEGENERATION; ELECTROMYOGRAPHY; KNOCKOUT MOUSE; MOTOR PERFORMANCE; MOUSE; MUTANT; MYELINATION; MYOKYMIA; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NEUROPATHY; NONHUMAN; OPEN FIELD TEST; PERIPHERAL NERVE; PHENOTYPE; PRIORITY JOURNAL; RANVIER NODE; REGENERATION; STIMULATION; VELOCITY; WILD TYPE;

4-AMINOPYRIDINE; ANIMALS; ANXIETY; AXONS; BEHAVIOR, ANIMAL; ELECTROMYOGRAPHY; IMMUNOHISTOCHEMISTRY; ISAACS SYNDROME; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUSCLE, SKELETAL; MUTATION; NERVE TISSUE PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; POSTURAL BALANCE; POTASSIUM CHANNEL BLOCKERS; PSYCHOMOTOR PERFORMANCE;

EID: 84903265318     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000085     Document Type: Article

References (31)

1. Maddison P. Neuromyotonia. Clin Neurophysiol 2006;117:2118-27
2. Browne DL, Gancher ST, Nutt JG, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Gen 1994;8:136-40
3. Zimon M, Baets J, Almeida-Souza L, et al. Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Gen 2012;44: 1080-83
4. Caetano JS, Costa C, Baets J, et al. Autosomal recessive axonal neuropathy with neuromyotonia: A rare entity. Pediatr Neurol 2014;50: 104-7
5. Zhao H, Race V, Matthijs G, et al. Exome sequencing reveals HINT1 mutations as a cause of distal hereditary motor neuropathy [published online ahead of print October 9, 2013]. Eur J Hum Gen. doi: 10.1038/ejhg.2013.231.
6. Hahn AF, Parkes AW, Bolton CF, et al. Neuromyotonia in hereditary motor neuropathy. J Neurol Neurosurg Psychiatry 1991;54:230-35
7. Su T, Suzui M, Wang L, et al. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc Natl Acad Sci USA 2003;100: 7824-29
8. Li H, Zhang Y, Su T, et al. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 2006;25:713-21
9. Razin E, Zhang ZC, Nechushtan H, et al. Suppression of microphthalmia transcriptional activity by its association with protein kinase CYinteracting protein 1 in mast cells. J Biol Chem 1999;274:34272-76
10. Linde CI, Feng B, Wang JB, et al. Histidine triad nucleotide-binding protein 1 (HINT1) regulates Ca(2+) signaling in mouse fibroblasts and neuronal cells via store-operated Ca(2+) entry pathway. Am J Physiol Cell Physiol 2013;304:C1098-104
11. Goerlich O, Foeckler R, Holler E. Mechanism of synthesis of adenosine(5¶)tetraphospho(5¶)adenosine (AppppA) by aminoacyl-tRNA synthetases. Eur J Biochem 1982;126:135-42
12. Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Gen 2003;72:1293-99
13. Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006;38:197-202
14. Latour P, Thauvin-Robinet C, Baudelet-Mery C, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Gen 2010;86:77-82
15. Seburn KL, Nangle LA, Cox GA, et al. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 2006;51:715-26
16. Wooley CM, Sher RB, Kale A, et al. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 2005;32:43-50
17. Wooley CM, Xing S, Burgess RW, et al. Age, experience and genetic background influence treadmill walking in mice. Physiol Behav 2009;96: 350-61
18. Burgess RW, Cox GA, Seburn KL. Neuromuscular disease models and analysis. Methods Mol Biol 2010;602:347-93
19. Motley WW, Seburn KL, Nawaz MH, et al. Charcot-Marie-ToothYlinked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Gen 2011;7:e1002399
20. Varadarajulu J, LebarM, Krishnamoorthy G, et al. Increased anxiety-related behaviour in Hint1 knockout mice. Behav Brain Res 2011;220:305-11
21. Achilli F, Bros-Facer V, Williams HP, et al. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Models Mech 2009;2:359-73
22. Toyka KV, Zielasek J, Ricker K, et al. Hereditary neuromyotonia: A mouse model associated with deficiency or increased gene dosage of the PMP22 gene. J Neurol Neurosurg Psychiatry 1997;63:812-13
23. Zielasek J, Toyka KV. Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies. Ann NY Acad Sci 1999;883:310-20
24. Zielasek J, Martini R, Suter U, et al. Neuromyotonia in mice with hereditary myelinopathies. Muscle Nerve 2000;23:696-701
25. Patton BL, Wang B, Tarumi YS, et al. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination. J Cell Sci 2008;121:1593-604
26. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995;38:714-22
27. Brunetti O, Imbrici P, Botti FM, et al. Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature. Neurobiol Dis 2012;47:310-21
28. Bangratz M, Sarrazin N, Devaux J, et al. A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking. Am J Pathol 2012;180: 2040-55
29. Stum M, Girard E, Bangratz M, et al. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia. Hum Mol Gen 2008;17:3166-79
30. Wang J, Fang P, Schimmel P, et al. Side chain independent recognition of aminoacyl adenylates by the Hint1 transcription suppressor. J Phys Chem B 2012;116:6798-805
31. Bieganowski P, Garrison PN, Hodawadekar SC, et al. Adenosine monophosphoramidase activity of Hint and Hnt1 supports function of Kin28, Ccl1, and Tfb3. J Biol Chem 2002;277:10852-60